158 related articles for article (PubMed ID: 25162329)
1. Re: Efficacy and safety of mirodenafil for patients with erectile dysfunction: a meta-analysis of three multicenter, randomized, double-blind, placebo-controlled clinical trials.
Li J; Shi Q; Wei Q; Han P
Aging Male; 2015 Jun; 18(2):71. PubMed ID: 25162329
[No Abstract] [Full Text] [Related]
2. Efficacy and safety of mirodenafil for patients with erectile dysfunction: a meta-analysis of three multicenter, randomized, double-blind, placebo-controlled clinical trials.
Du W; Li J; Fan N; Shang P; Wang Z; Ding H
Aging Male; 2014 Jun; 17(2):107-11. PubMed ID: 24219508
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of oral mirodenafil in the treatment of erectile dysfunction in diabetic men in Korea: a multicenter, randomized, double-blind, placebo-controlled clinical trial.
Park HJ; Choi HK; Ahn TY; Park JK; Chung WS; Lee SW; Kim SW; Hyun JS; Park NC
J Sex Med; 2010 Aug; 7(8):2842-50. PubMed ID: 20626604
[TBL] [Abstract][Full Text] [Related]
4. The penile erection efficacy of a new phosphodiesterase type 5 inhibitor, mirodenafil (SK3530), in rabbits with acute spinal cord injury.
Jung JY; Kim SK; Kim BS; Lee SH; Park YS; Kim SJ; Choi C; Yoon SI; Kim JS; Cho SD; Im GJ; Lee SM; Jung JW; Lee YS
J Vet Med Sci; 2008 Nov; 70(11):1199-204. PubMed ID: 19057138
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of mirodenafil in men taking antihypertensive medications.
Paick JS; Kim JJ; Kim SC; Moon KH; Min KS; Park K; Suh JK; Yang DY
J Sex Med; 2010 Sep; 7(9):3143-52. PubMed ID: 20649936
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of mirodenafil, a new oral phosphodiesterase type 5 inhibitor, for treatment of erectile dysfunction.
Paick JS; Ahn TY; Choi HK; Chung WS; Kim JJ; Kim SC; Kim SW; Lee SW; Min KS; Moon KH; Park JK; Park K; Park NC; Suh JK; Yang DY; Jung HG
J Sex Med; 2008 Nov; 5(11):2672-80. PubMed ID: 18638004
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of once daily administration of 50 mg mirodenafil in patients with erectile dysfunction: a multicenter, double-blind, placebo controlled trial.
Chung JH; Kang DH; Oh CY; Chung JM; Lee KS; Kim TH; Moon KH; Lee W; Cho JM; Lee SW
J Urol; 2013 Mar; 189(3):1006-13. PubMed ID: 23017527
[TBL] [Abstract][Full Text] [Related]
8. Erectile response to type 5 phosphodiesterase inhibitor could be preserved with the addition of simvastatin to conventional insulin treatment in rat model of diabetes.
Park K; Cho SY; Kim SW
Int J Androl; 2011 Oct; 34(5 Pt 2):e468-74. PubMed ID: 21790657
[TBL] [Abstract][Full Text] [Related]
9. Re: Efficacy of Once-Daily Administration of Udenafil for 24 Weeks on Erectile Dysfunction: Results from a Randomized Multicenter Placebo-Controlled Clinical Trial.
Seftel AD
J Urol; 2015 Aug; 194(2):495. PubMed ID: 26195408
[No Abstract] [Full Text] [Related]
10. Efficacy and tolerability of udenafil in Turkish men with erectile dysfunction of psychogenic and organic aetiology: a randomized, double-blind, placebo-controlled study.
Ortaç M; Çayan S; Çalişkan MK; Yaman MÖ; Okutucu TM; Semerci MB; Altay AB; Balbay MD; Özcan MF; Kadioğlu A
Andrology; 2013 Jul; 1(4):549-55. PubMed ID: 23785019
[TBL] [Abstract][Full Text] [Related]
11. Impact of the change in urinary and sexual function on health-related quality of life after once daily low-dose mirodenafil treatment in patients with organic erectile dysfunction.
Lee DS; Choe HS; Kim SW; Jung KU; Lee SJ
Urol Int; 2014; 93(1):84-91. PubMed ID: 24457224
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of phosphodiesterase-5 inhibitors for treating erectile dysfunction in kidney transplant recipients: a meta-analysis.
Fanbin L; Mei Y; Yan Z; Yirong Y; Shaoling Z; Yong C; Peng X
Exp Clin Transplant; 2014 Jun; 12(3):184-9. PubMed ID: 24907716
[TBL] [Abstract][Full Text] [Related]
13. Re: Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study.
Seftel AD
J Urol; 2014 Apr; 191(4):1077-8. PubMed ID: 24703142
[No Abstract] [Full Text] [Related]
14. Efficacy and safety of once-daily dosing of udenafil in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial.
Zhao C; Kim SW; Yang DY; Kim JJ; Park NC; Lee SW; Paick JS; Ahn TY; Min KS; Park K; Park JK
Eur Urol; 2011 Aug; 60(2):380-7. PubMed ID: 21458153
[TBL] [Abstract][Full Text] [Related]
15. A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Therapeutic Confirmatory Study to Evaluate the Safety and Efficacy of Avanafil in Korean Patients with Erectile Dysfunction.
Park HJ; Kim SW; Kim JJ; Lee SW; Paick JS; Ahn TY; Park K; Park JK; Park NC
J Korean Med Sci; 2017 Jun; 32(6):1016-1023. PubMed ID: 28480661
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of once-daily administration of udenafil for 24 weeks on erectile dysfunction: results from a randomized multicenter placebo-controlled clinical trial.
Moon KH; Ko YH; Kim SW; Moon du G; Kim JJ; Park NC; Lee SW; Paick JS; Ahn TY; Chung WS; Min KS; Park JK; Yang DY; Park K
J Sex Med; 2015 May; 12(5):1194-201. PubMed ID: 25736397
[TBL] [Abstract][Full Text] [Related]
17. Exploratory Decision-Tree Modeling of Data from the Randomized REACTT Trial of Tadalafil Versus Placebo to Predict Recovery of Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy.
Montorsi F; Oelke M; Henneges C; Brock G; Salonia A; d'Anzeo G; Rossi A; Mulhall JP; Büttner H
Eur Urol; 2016 Sep; 70(3):529-37. PubMed ID: 26947602
[TBL] [Abstract][Full Text] [Related]
18. Re: Comparative effectiveness and safety of oral phosphodiesterase type 5 inhibitors for erectile dysfunction: a systematic review and network meta-analysis.
Seftel A
J Urol; 2013 Oct; 190(4):1340. PubMed ID: 24029345
[No Abstract] [Full Text] [Related]
19. Efficacy of udenafil for the treatment of erectile dysfunction up to 12 hours after dosing: a randomized placebo-controlled trial.
Park HJ; Park JK; Park K; Min K; Park NC
J Sex Med; 2010 Jun; 7(6):2209-2216. PubMed ID: 20412426
[TBL] [Abstract][Full Text] [Related]
20. Newer phosphodiesterase inhibitors: comparison with established agents.
McNamara ER; Donatucci CF
Urol Clin North Am; 2011 May; 38(2):155-63. PubMed ID: 21621082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
